The new European Supply Chain Law and a Transatlantic partnership
September 6, 2024 by Giuliana Miglierini The new EU Corporate Sustainability Due Diligence Directive (EU) 2024/1760 (CSDDD), also…
The EU Parliament voted its position on the Unitary SPC
by Giuliana Miglierini The intersecting pathways of revision of the pharmaceutical and intellectual property legislations recently marked the…
Reform of pharma legislation: the debate on regulatory data protection
by Giuliana Miglierini As the definition of the final contents of many new pieces of the overall revision…
EC Communication (part 1): How to address critical medicines shortages
by Giuliana Miglierini As announced on 3 October in the speech given by Commissioner Stella Kyriakides at European…
The proposals of the EU Commission for the revision of the IP legislation
By Giuliana Miglierini In parallel to the new pharmaceutical legislation, on 27 April 2023 the EU Commission issued…
Review of the pharmaceutical legislation, the proposals of the industrial associations
By Giuliana Miglierini The Staff Working Document on “Vulnerabilities of the global supply chains of medicines” published by…